Joel Berg
Joel Berg is a freelance writer based in York, Pennsylvania. He has covered healthcare and financial services, as well as general business news, for more than 20 years. He also teaches writing at York College and Millersville University.
-
MedShift CEO shares vision for growth
A veteran of GE Healthcare, Joe Gasque talks about how he's growing the company's niche position in the high-paced aesthetics industry, offering services to surgeons, practitioners, medical device and injectables manufacturers.
-
Project seeks to chart regulatory paths for digital products
The nonprofit Digital Medicine Society is partnering with the likes of Google and the FDA to develop a free resource designed to help digital health startups navigate the regulatory process.
-
Payer’s Place: Dawn Maroney
Dawn Maroney, President, Markets of Alignment Health and CEO of Alignment Health Plan, to discuss how they are using technology to provide better service and care to consumers.
-
Employee Benefits, Startups, SYN
Study shows tech-based program improves workers’ mental health, productivity
The peer-reviewed research is among the first to examine the effectiveness of the new crop of digital mental health startups. It looked at people enrolled through their companies in a mental health platform developed by Spring Health.
-
Report: Deals continue downward slide for biopharma tech
During first three months of 2022, biopharma tech companies raised less money and made fewer deals than they did in the last three months of 2021. A volatile stock market is exacerbating the trend.
-
Investors funnel $40M into high-tech benefits brokerage
Armed with fresh capital, Nava Benefits hopes to take advantage of what it believes will be a disruption in the way smaller businesses approach health and wellness benefits, including the many digital tools now on the market.
-
BioPharma, Pharma, Policy, Social Determinants, SYN
Drug-industry survey blames insurer practices for barriers to care
Pharma companies often take the blame for high prescription costs. But a new, industry-sponsored survey shifts attention to insurance industry practices.
-
Novel drug-discovery approach lands big backers
UK-based OMass Therapeutics is leaning on a proprietary form of native mass spectrometry to help develop small-molecule drugs for rare diseases.
-
New Quest Alzheimer’s blood test can help clinical trial sponsors identify patients easily
The tests could prove useful in screening patients that coud benefit from therapies being tested for Alzheimer’s. But uptake will depend, in part, on reimbursement, according to doctors surveyed by Quest.
-
Startup focused on fertility planning raises $2.8M in seed funding
San Francisco-based Frame Fertility has developed a platform geared toward helping people get a headstart on issues that could impact their ability to have children instead of waiting until problems crop up.
-
Applying Remote Patient Monitoring to Surgery Prep and Recovery, Oncology and Women’s Health
Join us to learn about the latest trends in remote monitoring and how to extend its benefits beyond chronic conditions to more patients – all while using fewer staff resources.
-
Report: In big shift, medtech executives grow fonder of U.S. regulatory process
Executives used to lean toward European regulators launching their products in that region. But after a decade of change, they now see the U.S. as a better option. While the FDA gets kudos, the other issue remains challenging: reimbursement.
-
Thread, AWS partner on next-gen tech for clinical trials
The partners aim to make decentralized clinical trials more efficient and less expensive through greater use of AI and machine learning.
-
New tool aims to ease search for digital health vendors
Brokerage firm Nava Benefits hopes its search engine will become a trusted source of information on thousands of digital health startups aiming to sell their services to employers.
-
Devices & Diagnostics, Artificial Intelligence
Diagnostics firm adds investor to bring funding over $20M
Prenosis is aiming for FDA clearance this year for a diagnostic tool for sepsis, a condition that kills millions of people each year.
-
Legislative victories fuel advocates for coverage of biomarker testing
Lawmakers have acted to strengthen insurance reimbursement for biomarker testing in California, Illinois and Louisiana. Patient advocates and testing companies hope more will act in the coming year.
-
Startups see new promise in old insight about viruses to stop cancer
Researchers have known for decades that viruses can beat back cancer. But it’s been hard to design a virus that does the trick. A new wave of startups is optimistic they have found the keys.
Promoted
Payer’s Place: Dr. Anil Singh
Dr. Anil Singh shares his insights into the strategies employed by the organization to identify the most effective digital solutions for their members.
Promoted
Discover the Next-Gen Platform for Integrated Collaborative Care
Beyond EHRs and digital front doors, reducing the gaps in patient care journeys.
